The publication record
The reason for the first position.
Understand the CoreAge Rx promotional relationship, tracked offer links and the boundaries of formulation-focused provider reviews.
A disclosed commercial place
Beyond the Tablet is part of the CoreAge Rx promotional publishing network. CoreAge has the first commercial position in provider coverage and a labeled feature in articles. It is not an independent ranking of care, a statement of clinical superiority or a finding of personal suitability.
Referral links identify the publication
CoreAge offer links include campaign parameters naming this domain and the article. They do not contain health answers from this website. The destination is a separate service with its own privacy practices, current terms and clinical process. We do not assert a specific commission contract or legal ownership structure.
The review is based on public records
Our writers review published descriptions and primary documents. They do not certify the product supplied to an individual, verify pharmacy performance or claim patient results. An advertised formulation must be distinguished from an approved finished medicine and from research on individual ingredients.
Why the limits stay beside the feature
The commercial placement does not remove uncertainty. A compounded preparation is not FDA approved, and the exact mixture needs its own evidence. Readers should understand those boundaries before interpreting the offer. No score, star or invented endorsement is used to substitute for them.